NL-OMON51261招募中不适用
Immunological and molecular effects of MR-guided stereotactic radiotherapy in adrenal metastases - A hypothesis generating trial (IM-SABR) - IM-SABR
适应症
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 入组人数
- 30
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •In order to be eligible to participate in this study, a subject must meet all
- •of the following criteria:
- •1. Have adrenal metastases, for which MR-guided SABR has been recommended
- •following dis-cussions within a multi-disciplinary tumor board.
- •2. Be willing and able to provide written informed consent for the trial.
- •3. Be 18 years of age on day of signing informed consent.
排除标准
- •1. Has a diagnosis of immunodeficiency or is receiving systemic steroid therapy
- •or any other form of immunosuppressive therapy within 30 days prior to the
- •MR-guided SABR.
- •2. Has had prior chemotherapy, targeted small molecule therapy, or radiotherapy
- •within 30 days prior to MR-guided SABR.
- •3. Has a known additional malignancy that is progressing or requires active
- •treatment. Exceptions include basal cell carcinoma of the skin, squamous cell
- •carcinoma of the skin, or in situ cervical cancer that has undergone
- •potentially curative therapy.
- •4. Has an active autoimmune disease requiring systemic treatment within the
- •past 3 months or a syndrome that requires systemic steroids or
- •immunosuppressive agents. Subjects that require intermittent use of
- •bronchodilators or local steroid injections would not be excluded from the
- •study. Subjects with hypothyroidism stable on hormone replacement will not be
- •excluded from the study.
- •5. Has an active infection requiring systemic therapy.
- •6. Has a history or current evidence of any condition, therapy, or laboratory
- •abnormality that might confound the results of the trial, interfere with the
- •subject*s participation for the full du-ration of the trial, or is not in the
- •best interest of the subject to participate, in the opinion of the treating
- •investigator.
- •7. Has a known history of Human Immunodeficiency Virus (HIV) (HIV 1/2
- •antibodies) or a known active Hepatitis B (e.g., HBsAg reactive) or Hepatitis C
- •(e.g., HCV RNA [qualitative] is detected).
研究者
相似试验
招募中
1 期
Efficay of immunotherapy berfore surgery for localized dMMR colon cancerPatients with early stage (stage I-III) dMMR colon cancerMedDRA version: 21.0Level: LLTClassification code 10009951Term: Colon cancer NOSSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)EUCTR2021-006046-12-DKRigshospitalet85
已完成
1 期
Safety and efficacy of Magnetic Resonance-guided Focused Ultrasound Surgery (MRgFUS) for the treatment of chronic low back pain originating in lumbar facet joint osteoarthritis of elderly patients.JPRN-UMIN000015416Department of Orthopaedic Surgery, Kochi Medical School, Kochi University25
尚未招募
不适用
Role of MRI in the evaluation of age releted changes of lumbar spine.CTRI/2018/05/013921Government Medical College and Sir T Hospital Bhavnagar
已完成
不适用
Treatment of warts in children with MMR vaccineCTRI/2017/11/010344il165
已完成
不适用
To study the efficacy of intralesional MMR (Measles, Mumps, Rubella) vaccine for treating common wartsCTRI/2017/09/009870il165